STARPHARMA HOLDINGS LIMITED - Charts / Financials

4.76%

10.0¢

Market Cap $41.82M

Healthcare Biotechnology

Starpharma Holdings Limited is an Australia-based biotechnology company. The principal... Starpharma Holdings Limited is an Australia-based biotechnology company. The principal activities of the Company consist of research, development and commercialization of dendrimer products for pharmaceutical and healthcare applications. Its portfolio of dendrimer-based products includes three clinical-stage DEP (dendrimer enhanced product) assets, preclinical radiopharmaceutical assets, research collaborations, and three commercially marketed over-the-counter (OTC) products. It has developed a pipeline of novel DEP oncology products. Its clinical-stage assets, DEP SN38, DEP cabazitaxel, and DEP docetaxel, are dendrimer-based chemotherapeutic drugs. Additionally, it has a preclinical pipeline of DEP radiopharmaceuticals and DEP Antibody-Drug Conjugates (ADCs) in development. Its VIRALEZE Nasal Spray is a broad-spectrum nasal spray intended to provide a protective barrier in the nose that traps and blocks cold/respiratory viruses. It also offers VivaGel BV and VivaGel Condom products. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

REFRESH

Day
Open	10.5¢		Day High	10.5¢		Day Low	10.0¢
Daily Volume	399699

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
7	9.6¢	359599		2	10.5¢	209650

Directors & Senior Management

Ms. Cheryl Maley	Chief Executive Officer, Managing Director, Director
Mr. Justin W. Cahill	Chief Financial Officer, Company Secretary
Dr. Jeremy R. Paull	Vice President - Development and Regulatory Affairs
Dr. A Tony Eglezos	Vice President - Business Development
Mr. Robert Bain Thomas	Independent Non-Executive Chairman of the Board
Dr. Russell Basser	Independent Non-Executive Director
Ms. Lynda Cheng	Independent Non-Executive Director
Dr. Jeff R. Davies	Independent Non-Executive Director
Mr. David John Mcintyre	Independent Non-Executive Director

Data source: Refinitiv

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 10.0¢		Change -0.005(4.76%)		Mkt cap ! $41.82M

Open	High	Low	Value	Volume
10.5¢	10.5¢	10.0¢	$41.09K	399.6K

Buyers (Bids)

No.	Vol.	Price($)
7	359599	9.6¢

Sellers (Offers)

Price($)	Vol.	No.
10.5¢	209650	2

View Market Depth

No.	Vol.	Price($)
7	359599	0.096
4	180831	0.095
1	50000	0.093
1	10989	0.091
2	350000	0.090

Price($)	Vol.	No.
0.105	200000	1
0.110	340707	7
0.115	183999	4
0.120	64000	2
0.125	66309	2

Last trade - 16.10pm 08/08/2025 (20 minute delay)

SPL (ASX) Chart

STARPHARMA HOLDINGS LIMITED - Charts / Financials

Corporate SpotlightNot Yet Available

Directors & Senior Management

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available